Réseau Environnement Santé (RES) and Générations Futures invite you to the conference “Endocrine disruption : Public Health’s new frontier ?” – a lecture by Pr. Andreas Kortenkamp followed by an opened Q&A session.
The conference will be held in English with consecutive French translation.
When: April 26th, 14h-17h30
Where : French Senate, Palais du Luxembourg, Salle Monnerville
15ter rue vaugirard
(Metro line 4 ODEON or RER line B LUXEMBOURG)
Nominative subscription is required before April 20th – please send your first and last names, the name of your organisation and your contact details to email@example.com
A detailed programme will be available soon. Attendance is limited to 117 seats with focus on stakeholders from French and EU on-going work on EDCs.
Post provided by campaign partner Réseau Environnement Santé (RES)
HEAL and PAN Europe recently launched this video clip to urge organisations to join the “EDC Free campaign” as part of activities in Pesticides Action Week (20-30 March 2013).
The theme of Pesticides Action Week was “Endocrine disrupting pesticides” with the overall aim being to highlight the risks to health and the environment from pesticides – and to promote alternatives. In Brussels, HEAL and PAN E held a briefing for journalists and the video is one of the outcomes of the event.
More information on activities during Pesticides Action week here
This report was written by a group of international experts who outline that evidence linking hormone-mimicking chemicals to human health problems has grown stronger over the past decade, becoming a “global threat” that should be addressed.
The Danish Ecological Council has recently launched a new documentary film entitled ‘Hazardous Chemicals in our Blood’ which focuses on endocrine disrupting phthalates in medical devices. Vulnerable patients can be exposed to EDCs every day in many hospitals.
Catheters, tubes, blood bags and other medical devices made of PVC contains, in many cases, hormone disrupting phthalates, which are added to make the plastic soft and pliable. The phthalates are especially problematic for vulnerable groups such as premature babies, children and pregnant women.
This film examines why these harmful chemicals are still present in medical devices and what action needs to be taken to ensure that no unnecessary exposure occurs via medical devices.
The results of the first part of an enquiry by French NGO, Generations Futures into everyday exposure to endocrine-disrupting pesticides was launched on 20 March 2013.
Act now: To demonstrate the urgency of preventative action on EDCs, Generations Futures has developed a series of reports based on analyses and in-depth surveys showing the omnipresence of many EDCs in our environment, which creates a very significant exposure for the population. This series of reports is called EXPPERT (in French, EXposition aux Pesticides PERTurbateurs endocriniens).
EXPPERT 1 shows that we are exposed on a daily basis to two families of endocrine disrupting (ED) insecticides: organophosphates and pyrethroids.
On 21 March 2013, EFSA released its opinion report on EDCs which is one of the several inputs that contribute to the European Commission’s development of criteria to identify chemicals with endocrine disrupting properties (or endocrine disruptors). The Commission is formulating criteria which can be used in various EU laws, to ensure that a chemical identified as an endocrine disruptor under one law is also considered an endocrine disruptor under a different law.
On 21 March 2013, Health Care Without Harm Europe (HCWH-E) organised a parliamentary lunch workshop to discuss why we should move towards a non-toxic European healthcare system and demand for alternatives to harmful chemicals in medical devices. The event was hosted by MEP Corine Lepage and aimed at contributing towards the current debate in the EP on the new Commission’s proposal on the Medical Device Regulation (COM(2012) 542 final).The workshop conveyed the opinion of medical device producers, doctors and hospital facility managers about their experience in producing, purchasing and using medical devices without EDCs and in particular phthalates.
HCWH-E calls on the legislators, hospital systems and the general public to increase the pressure on industry to encourage the production and commercialization of medical devices that do not contain phthalates and consequently cause no harm to the health of European citizens.